EDWARDS LIFESCIENCES REPORTS FIRST QUARTER RESULTS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- Lula, Brazil's iconic working class president, wins historic fourth term in dramatic comeback
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
- Accenture shares fall on insider sales and analyst downgrade
- Wall Street closes lower to end rocky week
- Credo Technology shares fall on competition concerns
Edwards Lifesciences (EW) Tops Q1 EPS by 3c
April 26, 2022 4:16 PM EDTEdwards Lifesciences (NYSE: EW) reported Q1 EPS of $0.60, $0.03 better than the analyst estimate of $0.57. Revenue for the quarter came in at $1.34 billion versus the consensus estimate of $1.31 billion.
GUIDANCE:
Edwards Lifesciences sees Q2 2022 EPS of $0.61-$0.69, versus the consensus of $0.65.... More



